Wordt geladen...
Feasibility of Reducing the Duration of Placebo-Controlled Trials in Schizophrenia Research
Use of placebo-controlled trials in medical and psychiatric research has been controversial, although a consensus is emerging about conditions under which placebo-controlled trials are ethical. In schizophrenia research, the paradigm of slow onset of antipsychotic effects has led to a model in which...
Bewaard in:
| Hoofdauteurs: | , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Oxford University Press
2008
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2632413/ https://ncbi.nlm.nih.gov/pubmed/18184634 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sbm152 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|